Go to content
Fagron NV

Fagron NV

Hieronder vindt u informatie uit het register openbaarmaking voorwetenschap. Deze informatie is door de organisatie verstrekt.

Publicatie datum 20 dec 2012 - 07:31
Statutaire naam Fagron NV
Titel Fagron strengthens its position in the United States through the acquisition of B&B Pharmaceuticals
Bericht Waregem (Belgium) / Rotterdam (the Netherlands)[1], 20 December 2012 -Arseus announces today that it has signed an agreement to acquire B&B Pharmaceuticals (www.bbpharm.net). B&B Pharmaceuticals,incorporated in 1997 and located in Aurora (Colorado), supplies controlled substances and pharmaceutical raw materials for pharmaceutical compounding to pharmacists in the United States. In 2012, B&B Pharmaceuticals' turnover is expected to be approximately US$ 6 million, with an EBITDA margin above the average for the Fagron Group. Fagron paid a multiple of 5.5 times EBITDA for this acquisition. B&B Pharmaceuticals will be consolidated as of 1 December 2012.